Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RWReeves who started this subject	7/22/2002 2:19:40 PM
From: Czechsinthemail	Read Replies (1) of 684

As of today, TTP has now dropped to less than 50% of its cash value. The company has cash of around $96 million and a burn rate of maybe $5-7 million per quarter. No debt and net cash value per share is about $3.40. The company has a number of prospects in its pipeline. Presumably, they will have to increase cash outlays to move candidates through trials. But the current share price effectively gives a net negative value to the pipeline.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next